| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pelthos Therapeutics Inc. (PTHS) has 10 insiders with recent SEC Form 4 filings, including 7 buys and 6 sells. PTHS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.0K | $7.39M | - | |
| Other | 93.0K | $2.70M | - | |
| Dir | 81.7K | $2.37M | -283 | |
| Dir | 75.8K | $2.20M | +35.9K | |
| CFO | 33.5K | $970.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Friedberg Ezra M | Director | Sell | 283 | $27.29 | $7,724.37 | -0.2% | - | - | |
| Jun 11, 2026 | Davis Todd C78 | Director | Buy | 35,948 | $27.82 | $999,983.28 | +31.2% | - | - | |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell | 10,000 | $28.03 | $280,280.50 | -7.2% | -10.0% | - | |
| Sep 13, 2024 | Francis Knuettel II68 | CEO, Pres., CFO, Treas &Secty | Buy | 5,200 | $0.97 | $5,044.00 | +0.5% | -25.6% | +251.1% | |
| Sep 12, 2024 | Malamut Richard | Director | Buy | 10,400 | $0.94 | $9,824.88 | +12.8% | -33.6% | +231.7% | |
| Sep 11, 2024 | Francis Knuettel II68 | CEO, Pres., CFO, Treas &Secty | Buy | 12,000 | $0.91 | $10,955.00 | +1.1% | -35.4% | +233.2% |